微盟集團(2013.HK)漲超7%持續走強 “超級聯盟”平台重磅上線
格隆匯12月17日丨近日持續走強的微盟集團(2013.HK)今日漲勢繼續,盤中一度拉昇漲7.64%至12.68港元,股價創9月初以來新高,市值超280億港元。近日,微盟正式上線異業私域合作平台“超級聯盟”,品牌商家可通過該平台實現私域流量價值互換和用户運營增值升級,以突破現有流量瓶頸。分析人士指出,微盟此次“超級聯盟”平台為微商城&智慧零售推出,向SaaS業務兩大重頭出擊,主打異業私域合作,精準匹配商家訴求,高效解決商家經營難題,縮短合作鏈路,具有較高自主性,是微盟在SaaS業務上又一次創新。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.